These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Toll-like receptors and danger signaling in kidney injury. Anders HJ J Am Soc Nephrol; 2010 Aug; 21(8):1270-4. PubMed ID: 20651159 [TBL] [Abstract][Full Text] [Related]
8. Expression of Toll-like receptors in the kidney: their potential role beyond infection. Schroppel B; He JC Kidney Int; 2006 Mar; 69(5):785-7. PubMed ID: 16518338 [TBL] [Abstract][Full Text] [Related]
9. [Innate immunity, receptors for exogenous and endogenous danger patterns in immunopathogenesis of atherosclerosis--part 1: identification of danger signals by innate immunity]. Krejsek J; Kunes P; Andrýs C; Holická M; Novosad J; Kudlová M; Kolácková M Cas Lek Cesk; 2005; 144(12):785-9. PubMed ID: 16389747 [TBL] [Abstract][Full Text] [Related]
10. How the Innate Immune System Senses Trouble and Causes Trouble. Hato T; Dagher PC Clin J Am Soc Nephrol; 2015 Aug; 10(8):1459-69. PubMed ID: 25414319 [TBL] [Abstract][Full Text] [Related]
11. Small Leucine-Rich Proteoglycans in Renal Inflammation: Two Sides of the Coin. Nastase MV; Janicova A; Roedig H; Hsieh LT; Wygrecka M; Schaefer L J Histochem Cytochem; 2018 Apr; 66(4):261-272. PubMed ID: 29290137 [TBL] [Abstract][Full Text] [Related]
12. Innate immune recognition. Janeway CA; Medzhitov R Annu Rev Immunol; 2002; 20():197-216. PubMed ID: 11861602 [TBL] [Abstract][Full Text] [Related]
13. Extracellular matrix molecules: endogenous danger signals as new drug targets in kidney diseases. Schaefer L Curr Opin Pharmacol; 2010 Apr; 10(2):185-90. PubMed ID: 20045380 [TBL] [Abstract][Full Text] [Related]
14. Signal integration following Toll-like receptor triggering. Dalpke A; Heeg K Crit Rev Immunol; 2002; 22(3):217-50. PubMed ID: 12498384 [TBL] [Abstract][Full Text] [Related]
15. Toll-like receptors: a family of innate sensors of danger that alert and drive immunity. Montero Vega MT; de Andrés Martín A Allergol Immunopathol (Madr); 2008; 36(6):347-57. PubMed ID: 19150035 [TBL] [Abstract][Full Text] [Related]
16. Toll-like receptors and their role in renal pathologies. Eleftheriadis T; Pissas G; Liakopoulos V; Stefanidis I; Lawson BR Inflamm Allergy Drug Targets; 2012 Dec; 11(6):464-77. PubMed ID: 22931389 [TBL] [Abstract][Full Text] [Related]
17. TLRs and chronic inflammation. Ospelt C; Gay S Int J Biochem Cell Biol; 2010 Apr; 42(4):495-505. PubMed ID: 19840864 [TBL] [Abstract][Full Text] [Related]
18. Activation of the Innate Immune Receptors: Guardians of the Micro Galaxy : Activation and Functions of the Innate Immune Receptors. De Nardo D Adv Exp Med Biol; 2017; 1024():1-35. PubMed ID: 28921463 [TBL] [Abstract][Full Text] [Related]
19. Toll-like receptors (TLRs) in aquatic animals: signaling pathways, expressions and immune responses. Rauta PR; Samanta M; Dash HR; Nayak B; Das S Immunol Lett; 2014; 158(1-2):14-24. PubMed ID: 24291116 [TBL] [Abstract][Full Text] [Related]
20. Toll-like receptors in central nervous system glial inflammation and homeostasis. Kielian T J Neurosci Res; 2006 Apr; 83(5):711-30. PubMed ID: 16541438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]